Related Experiment Video
Updated: Oct 28, 2026
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
Colorectal Cancer among U.S. Adults, 2000-2023
Caitlin C Murphy1,2,3, Folasade P May4,5, Sonia S Kupfer3,6
1Section of Hematology/Oncology, Department of Pediatrics, The University of Chicago, Chicago, IL, USA.
Abstract:
AbstractUsing data from the National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) Program, we examined colorectal cancer incidence rates in the United States between 2000 and 2023. SEER 21 covers 45.8% of the U.S. population. The age-adjusted incidence rate was 55.2 per 100,000 (95% CI, 54.8 to 55.6) in 2000, 36.7 per 100,000 (95% CI, 36.4 to 37.0) in 2022, and 38.3 per 100,000 (95% CI, 38.0 to 38.6) in 2023. The apparent increase in 2023 was the first since the inception of SEER 21 and warrants additional surveillance and investigation.
Related Concept Videos
02:59Cancer Prevention
Some...
02:07Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...